REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/02/2025
Voltar para busca
Dado oficial do USPTO
COVANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
COVANCE
ST13
US500000086567126Classe
9, 16, 31, 35, 36, 42, 44, 45
Pedido
86567126
Registro
4897520
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
09/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 16, 31, 35, 36, 42, 44, 45
Data de depósito
17/03/2015
Data de registro
09/02/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/11/2021
Última transação
09/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Primeiro uso
1996-11-00
Primeiro uso no comércio
1996-11-00
Código do desenho
4
Tipo de titular
03
Localização do titular
PRINCETON, NJ
Examinador
SPARACINO, MARK
Unidade examinadora
L30
Titulares e representantes
Titulares
LABCORP DRUG DEVELOPMENT INC.
Covance Inc.
Representantes
William M. Bryner Kilpatrick Townsend & Stockton LLP
Classificação técnica
Classes Nice
Classe 9Classe 16Classe 31Classe 35Classe 36Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable electronic publicationsbookspamphletsarticlestechnical manualsinstructional and teaching materialsreports in the fields of research and development of pharmaceuticalmedical devicesbiotechnologybiochemicals
Classe 16
Printed matterbookspamphletsarticlestechnical manualsinstructional and teaching materialsreports in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals
Classe 31
Live animals; live laboratory animals
Classe 35
Business consultancy services; business management consultancy and advisory services; consultancy and advisory services in the field of business strategy; marketing services; regulatory submission managementassisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; market research; business consulting services in the field of commercialization of pharmaceuticalsmedical devicesbiotechnologybiochemicals; business management servicesforecasting drug supplies for clinical trials; business management servicesrecruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; project management services for others for business purposes in the field of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; database management; business information services; business data analysis; business advice and commercial information
Classe 36
Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs
Classe 42
Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformaticsbiomarkersgenomicsproteomicsgenotypinggenetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; computer hardware and software design; developmentupdating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; data mining; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safetyfood packagingnutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug developmentselecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug developmentselecting biomarkers for use in testing drugs; lead candidate drug optimization servicesscientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistrypharmaceuticals and clinical trials; providing online non-downloadable software for trackingmonitoringanalyzinggenerating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices
Classe 44
Medical services in the fields of pathologypharmacologyimmunology; medical and psychological counseling; providing medical information and advice in the fields of pathologypharmacologyimmunology; collectionorganizationanalysisreporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
Classe 45
Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; providing information and advisory services about regulatory compliance in the fields of pharmaceuticalsmedical devicesfood safetynutritional labeling
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/09/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/11/2021
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/11/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/11/2021
E815
TEAS SECTION 8 & 15 RECEIVED
30/07/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/09/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/11/2015
PUBO
PUBLISHED FOR OPPOSITION
24/11/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2015
DOCK
ASSIGNED TO EXAMINER
07/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/06/2015
GNRT
NON-FINAL ACTION E-MAILED
23/06/2015
CNRT
NON-FINAL ACTION WRITTEN
23/06/2015
DOCK
ASSIGNED TO EXAMINER
19/06/2015
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/04/2015
ALIE
ASSIGNED TO LIE
06/04/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
30/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/03/2015
NWAP
NEW APPLICATION ENTERED
20/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COVANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.